{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:39:47Z","timestamp":1792507187738,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ijmm.2007.09.007","type":"journal-article","created":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T15:12:52Z","timestamp":1206803572000},"page":"345-364","source":"Crossref","is-referenced-by-count":38,"title":["Bacillus anthracis: Balancing innocent research with dual-use potential"],"prefix":"10.1016","volume":"298","author":[{"given":"Michael J.","family":"Hudson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fasanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Garofolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Golinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre L.","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Hallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tim.2004.12.004","article-title":"Anthrax toxin: the long and winding road that leads to the kill","volume":"13","author":"Abrami","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib2","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1128\/JCM.43.9.4780-4788.2005","article-title":"Production and validation of the use of gamma phage for identification of Bacillus anthracis","volume":"43","author":"Abshire","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2672.2006.03112.x","article-title":"Past, imminent and future human medical countermeasures for anthrax","volume":"101","author":"Baillie","year":"2006","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2006.07.002","article-title":"Anthrax toxins: a paradigm of bacterial immune suppression","volume":"27","author":"Baldari","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib5","first-page":"508","article-title":"Vaccination strategies for anthrax prevention","volume":"117","author":"Beyer","year":"2004","journal-title":"Berl. M\u00fcnch. Tierarztl. Wochenschr."},{"key":"10.1016\/j.ijmm.2007.09.007_bib6","first-page":"653","article-title":"Status quo of detection methods for Bacillus anthracis in clinical and environmental samples","volume":"58","author":"Beyer","year":"2003","journal-title":"Tieraerztl. Umschau"},{"key":"10.1016\/j.ijmm.2007.09.007_bib7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CDLI.11.1.50-55.2004","article-title":"Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins","volume":"11","author":"Biagini","year":"2004","journal-title":"Clin. Diag. Lab. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng1724","article-title":"Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin","volume":"38","author":"Boyden","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijmm.2007.09.007_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/IAI.01202-06","article-title":"Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis","volume":"75","author":"Bozue","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2007.09.007_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ijmm.2007.09.007_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2007.09.007_bib12","unstructured":"BWC, 2006a. Documents. The biological and toxin weapons convention and its status \u3008http:\/\/www.opbw.org\/\u3009."},{"key":"10.1016\/j.ijmm.2007.09.007_bib13","unstructured":"BWC, 2006b. Sixth Review Conference: Final Document 8 December 2006 \u3008http:\/\/www.opbw.org\/\u3009."},{"key":"10.1016\/j.ijmm.2007.09.007_bib14","unstructured":"CDC, 2006. Centers for Disease Control and Prevention. Bioterrorism Agents\/Diseases: By Category \u3008http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp\u3009."},{"key":"10.1016\/j.ijmm.2007.09.007_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxins","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib16","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1073\/pnas.062171599","article-title":"A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease","volume":"99","author":"Cummings","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib17","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1038\/sj.emboj.7601408","article-title":"Cell entry and cAMP imaging of anthrax edema toxin","volume":"25","author":"Dal Molin","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ijmm.2007.09.007_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.embor.7400118","article-title":"Potent inhibitors of anthrax lethal factor from green tea","volume":"5","author":"Dell\u2019Aica","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijmm.2007.09.007_bib19","series-title":"Proceedings of ARC-Ondersterpoort OIE International Congress with WHO \u2013 Co-sponsorship on Anthrax, Brucellosis, CBPP, Clostridial and Mycobacterial Diseases, 9\u201315 August 1998, Berg-en Dal, Kruger National Park","first-page":"16","article-title":"Anthrax in the Kruger National Park: an ecological approach to the question whether anthrax is indigenous to the Kruger National Park","author":"De Vos","year":"1998"},{"key":"10.1016\/j.ijmm.2007.09.007_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijmm.2007.09.007_bib21","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.4049\/jimmunol.176.10.6155","article-title":"Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production","volume":"176","author":"Fang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib22","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1016\/S0264-410X(01)00159-1","article-title":"Detection of anthrax vaccine virulence factors by polymerase chain reaction","volume":"19","author":"Fasanella","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2007.09.007_bib23","unstructured":"Fasanella, A., Schino, G., Schiavone, M.A., Losito, S., Buonavoglia, C., 2003. The presence of antibodies against Bacillus anthracis toxic factors in unvaccinated pastured sheep in Italy. In: Fifth International Conference on Anthrax, 30 March\u20133 April 2003, Nice, France."},{"key":"10.1016\/j.ijmm.2007.09.007_bib24","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/JCM.43.7.3398-3401.2005","article-title":"Molecular diversity of Bacillus anthracis in Italy","volume":"43","author":"Fasanella","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib25","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/JCM.40.12.4732-4734.2002","article-title":"Diversity among French Bacillus anthracis isolates","volume":"40","author":"Fouet","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib26","first-page":"394","article-title":"Immunity to anthrax: protective antigen present in cell-free culture filtrates","volume":"27","author":"Gladstone","year":"1946","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1462-5822.2006.00806.x","article-title":"Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores","volume":"9","author":"Glomski","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib28","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.4049\/jimmunol.178.5.2646","article-title":"IFN-\u03b3 producing CD4T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis","volume":"178","author":"Glomski","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib29","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2007.09.007_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biologicals.2003.09.003","article-title":"Validation of the anthrax lethal toxin neutralization assay","volume":"32","author":"Hering","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.ijmm.2007.09.007_bib31","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1073\/pnas.0402414101","article-title":"Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax","volume":"101","author":"Hoffmaster","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nature02405","article-title":"The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4","volume":"428","author":"Hsu","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2007.09.007_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2672.1999.00867.x","article-title":"1996\u201397 Global anthrax report","volume":"87","author":"Hugh-Jones","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.20506\/rst.21.2.1336","article-title":"Anthrax and wildlife","volume":"2","author":"Hugh-Jones","year":"2002","journal-title":"Rev. Sci. Tech."},{"key":"10.1016\/j.ijmm.2007.09.007_bib35","unstructured":"ICH Steering Committee, 1996. ICH harmonised tripartite guidelines. Validation of analytical procedures: methodology Q2. In: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step 4."},{"key":"10.1016\/j.ijmm.2007.09.007_bib36","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijmm.2007.09.007_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.meegid.2004.02.005","article-title":"Anthrax molecular epidemiology and forensics: using the appropriate marker for different evolutionary scales","volume":"4","author":"Keim","year":"2004","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib38","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1073\/pnas.0500508102","article-title":"Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tim.2006.08.001","article-title":"Defensin: a multifunctional molecule lives up to its versatile name","volume":"14","author":"Kim","year":"2006","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2672.2006.02809.x","article-title":"Evaluation of different methods to discriminate Bacillus anthracis from other bacteria of the Bacillus cereus group","volume":"100","author":"Klee","year":"2006","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib41","series-title":"Zweiter Band","first-page":"277","article-title":"Beitr\u00e4ge zur Biologie der Pflanzen","author":"Koch","year":"1876"},{"key":"10.1016\/j.ijmm.2007.09.007_bib42","volume":"271","year":"2002"},{"key":"10.1016\/j.ijmm.2007.09.007_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature02722","article-title":"Anthrax kills wild chimpanzees in a tropical rainforest","volume":"430","author":"Leendertz","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2007.09.007_bib44","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2180-6-33","article-title":"Genotyping of Bacillus anthracis strains based on automated capillary 25-loci multiple locus variable-number tandem repeats analysis","volume":"6","author":"Lista","year":"2006","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00063030-200519040-00003","article-title":"Anthrax vaccines \u2013 a development update","volume":"19","author":"Little","year":"2005","journal-title":"Biodrugs"},{"key":"10.1016\/j.ijmm.2007.09.007_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1365-2672.1999.00879.x","article-title":"Molecular recognition specificity of Bacillus anthracis spore antibodies","volume":"87","author":"Longchamp","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib49","unstructured":"Lord, A.M., 2001. A brief history of anthrax. Office of the Public Health Service Historian \u3008http:\/\/lhncbc.nlm.nih.gov\/apdb\/phsHistory\/resources\/pdf\/anthrax.pdf\u3009."},{"key":"10.1016\/j.ijmm.2007.09.007_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1128\/CVI.00023-06","article-title":"Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays","volume":"13","author":"Mabry","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2180-6-22","article-title":"Molecular approaches to identify and differentiate Bacillus anthracis from phenotypically similar Bacillus species isolates","volume":"6","author":"Marston","year":"2006","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib51","first-page":"216","article-title":"Human neutrophils kill Bacillus anthracis","volume":"119","author":"Mayer-Scholl","year":"2005","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijmm.2007.09.007_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.39.1.371-376.1983","article-title":"Evidence for plasmid mediated toxin production in Bacillus anthracis","volume":"39","author":"Mikesell","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2007.09.007_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2307\/4570379","article-title":"Experimental insect transmission of anthrax","volume":"29","author":"Mitzmain","year":"1914","journal-title":"Public Health Rep."},{"key":"10.1016\/j.ijmm.2007.09.007_bib54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tibs.2004.04.011","article-title":"Stop the killer: how to inhibit the anthrax lethal factor metalloprotease","volume":"29","author":"Montecucco","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijmm.2007.09.007_bib56","first-page":"606","article-title":"Some carriers of anthrax infection","volume":"56","author":"Morris","year":"1920","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.ijmm.2007.09.007_bib57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijmm.2007.09.007_bib58","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4161\/cc.6.6.3991","article-title":"Anthrax lethal toxin kills macrophages in a strain-specific manner by apoptosis or caspase-1-mediated necrosis","volume":"6","author":"Muehlbauer","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijmm.2007.09.007_bib59","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.2002.tb04386.x","article-title":"Emergency response planning for anthrax outbreaks in bison herds of northern Canada: a balance between policy and science","volume":"969","author":"Nishi","year":"2002","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.ijmm.2007.09.007_bib60","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1371\/journal.ppat.0020122","article-title":"Anthrax, but not Bacillus anthracis?","volume":"2","author":"Okinaka","year":"2006","journal-title":"PloS Pathog."},{"key":"10.1016\/j.ijmm.2007.09.007_bib61","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/431897b","article-title":"US restrictions limit anthrax networking","volume":"431","author":"Ozin","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2007.09.007_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling","volume":"201","author":"Paccani","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijmm.2007.09.007_bib63","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3201\/eid1004.030544","article-title":"Ruling out Bacillus anthracis","volume":"10","author":"Papaparaskevas","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ijmm.2007.09.007_bib64","first-page":"1378","article-title":"Compte rendu sommaire des exp\u00e9riences faites \u00e0 Pouilly-le-Fort, pr\u00e8s Melun, sur la vaccination charbonneuse","volume":"92","author":"Pasteur","year":"1881","journal-title":"C.R. Acad. Sci."},{"key":"10.1016\/j.ijmm.2007.09.007_bib65","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MMBR.68.4.617-629.2004","article-title":"Rabbit and nonhuman primate models of toxin-targeting human anthrax vaccines","volume":"68","author":"Phipps","year":"2004","journal-title":"Microb. Mol. Biol. Rev."},{"key":"10.1016\/j.ijmm.2007.09.007_bib66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.173.1.521","article-title":"High bactericidal efficiency of type IIA phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin","volume":"173","author":"Piris Gimenez","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib67","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.4049\/jimmunol.175.10.6786","article-title":"In vivo protective role of human group IIA phospholipase A2 against experimental anthrax","volume":"175","author":"Piris-Gimenez","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1042\/BJ20051747","article-title":"Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo","volume":"395","author":"Pini","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijmm.2007.09.007_bib69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1099\/mic.0.26681-0","article-title":"Identification of proteins in the exosporium of Bacillus anthracis","volume":"150","author":"Redmond","year":"2004","journal-title":"Microbiology"},{"key":"10.1016\/j.ijmm.2007.09.007_bib70","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib71","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0003-2697(03)00424-X","article-title":"An enzymatic electrochemiluminescence assay for the lethal factor of anthrax","volume":"321","author":"Rivera","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijmm.2007.09.007_bib72","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1462-5822.2006.00840.x","article-title":"Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signaling","volume":"9","author":"Rossi-Paccani","year":"2007","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib73","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AEM.72.5.3168-3174.2006","article-title":"Bacillus anthracis multiplication, persistence and genetic exchange in the rhizosphere of grass plants","volume":"72","author":"Saile","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib74","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly(\u03b3-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mib.2004.12.005","article-title":"Interactions between anthrax toxin receptors and protective antigen","volume":"8","author":"Scobie","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib76","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s00018-006-6312-3","article-title":"Anthrax vaccines: Pasteur to present","volume":"63","author":"Scorpio","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijmm.2007.09.007_bib77","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1073\/pnas.0306552101","article-title":"Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection","volume":"101","author":"Shen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2007.09.007_bib78","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1128\/JB.185.6.1903-1910.2003","article-title":"Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium","volume":"185","author":"Steichen","year":"2003","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib79","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1128\/JB.187.17.5868-5876.2005","article-title":"Characterization of the exosporium basal layer protein BxpB of Bacillus anthracis","volume":"187","author":"Steichen","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib80","first-page":"307","article-title":"The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis","volume":"13","author":"Sterne","year":"1939","journal-title":"Onderstepoort J. Vet. Sci. Anim. Ind."},{"key":"10.1016\/j.ijmm.2007.09.007_bib81","first-page":"1493","article-title":"Distribution and economic importance of anthrax","volume":"26","author":"Sterne","year":"1967","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ijmm.2007.09.007_bib82","unstructured":"Sylvestre, P., Tosi-Couture, E., Mock, M., 2001. Analysis of Bacillus anthracis spore surface antigens with monoclonal antibodies. In: Proceedings of the Fourth International Conference on Anthrax, Annapolis, MD, USA, June 10\u201313, 2001, p. 30."},{"key":"10.1016\/j.ijmm.2007.09.007_bib83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2958.2000.03000.x","article-title":"A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium","volume":"45","author":"Sylvestre","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib84","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1128\/JB.185.5.1555-1563.2003","article-title":"Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length","volume":"185","author":"Sylvestre","year":"2003","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib85","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1128\/JB.187.15.5122-5128.2005","article-title":"Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the Bacillus anthracis exosporium","volume":"187","author":"Sylvestre","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib86","series-title":"National Institute of Allergy and Infectious Diseases: Frontiers In Research 2006","article-title":"Spore surface components and protective immunity to Bacillus anthracis","author":"Sylvestre","year":"2008"},{"key":"10.1016\/j.ijmm.2007.09.007_bib87","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/418386a","article-title":"Pharmacology: screening inhibitors of anthrax lethal factor","volume":"418","author":"Tonello","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijmm.2007.09.007_bib88","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2672.2006.03087.x","article-title":"The Bacillus cereus group: novel aspects of population structure and genome dynamics","volume":"101","author":"Tourasse","year":"2006","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib89","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.4049\/jimmunol.174.8.4934","article-title":"Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells","volume":"174","author":"Tournier","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib90","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/vr.128.17.399","article-title":"Anthrax in wildlife in the Luangwa Valley, Zambia","volume":"17","author":"Turnbull","year":"1991","journal-title":"Vet. Rec."},{"key":"10.1016\/j.ijmm.2007.09.007_bib91","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2672.1999.00894.x","article-title":"Experiences with vaccination and epidemiological investigations on anthrax outbreak in Australia in 1997","volume":"87","author":"Turner","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib92","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1128\/IAI.55.8.1859-1861.1987","article-title":"Mechanical transmission of Bacillus anthracis by stable flies (Stomoxys calcitrans) and mosquitoes (Aedes aegypti and Aedes taeniorhynchus)","volume":"55","author":"Turrel","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2007.09.007_bib93","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1371\/journal.pone.0000461","article-title":"Global genetic population structure of Bacillus anthracis","volume":"2","author":"Van Ert","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijmm.2007.09.007_bib94","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages","volume":"248","author":"Vitale","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijmm.2007.09.007_bib95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1042\/0264-6021:3520739","article-title":"Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor","volume":"352","author":"Vitale","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijmm.2007.09.007_bib96","doi-asserted-by":"crossref","first-page":"32755","DOI":"10.1074\/jbc.M603614200","article-title":"Retrocyclins kill bacilli and germinating spores and inactivate anthrax lethal toxin","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijmm.2007.09.007_bib97","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.cell.2005.12.045","article-title":"The LDL receptor-related protein LPR6 mediates internalization and lethality of anthrax toxin","volume":"124","author":"Wei","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijmm.2007.09.007_bib98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0882-4010(88)90048-4","article-title":"Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis","volume":"4","author":"Welkos","year":"1988","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijmm.2007.09.007_bib99","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0738-081X(02)00250-X","article-title":"The story of anthrax from antiquity to the present: a biological weapon of nature and humans","volume":"20","author":"Witkowski","year":"2002","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ijmm.2007.09.007_bib100","unstructured":"WHO, 1998. Guidelines for the Surveillance and Control of Anthrax in Humans and Animals, third ed., WHO\/EMC\/ZDI.\/98.6. World Health Organization, Geneva."},{"key":"10.1016\/j.ijmm.2007.09.007_bib101","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.ppat.0030027","article-title":"LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin","volume":"3","author":"Young","year":"2007","journal-title":"PLoS Pathog."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143842210800009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143842210800009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T15:02:44Z","timestamp":1588518164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S143842210800009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":101,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S143842210800009X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2007.09.007","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}